BioTime (BTX) and Subsidiary LifeMap Sciences Announce Agreement to Acquire XenneX, Inc.  
4/20/2012 10:11:02 AM

ALAMEDA, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX) and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days.